The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis
Open accessAbstract
Background: Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is an increasingly recognized cause of heart failure in older individuals. We sought to characterize the natural history of ATTR-CM and compare outcomes and quality of life among patients with acquired and hereditary forms of the disease. Methods: We studied 711 patients with wild-type ATTR-CM, 205 with hereditary ATTR-CM associated with the V122I variant (V122I-hATTR-CM), and 118 with non-V122I-hATTR-CM at the UK National Amyloidosis Center between 2000 and 2017. Patients underwent prospective protocolized evaluations comprising assessment of cardiac parameters, functional status by 6-minute walk test, quality of life according to the Kansas City Cardiomyopathy Questionnaire, and survival. Hospital service usage pre- and postdiagnosis was established using English central health records in a subset of patients. Results: There was substantial diagnostic delay, with patients using hospital services a median (interquartile range) of 17 (9–27) times during the 3 years before diagnosis, by which time quality of life was poor; diagnosis of wild-type ATTR-CM was delayed >4 years after presentation with cardiac symptoms in 42% of cases. Patients with V122I-hATTR-CM were more impaired functionally ( P <0.001) and had worse measures of cardiac disease ( P <0.001) at the time of diagnosis, a greater decline in quality of life, and poorer survival ( P <0.001) in comparison with the other subgroups. Conclusions: ATTR-CM is an inexorably progressive and eventually fatal cardiomyopathy associated with poor quality of life. Diagnosis is often delayed for many years after symptoms develop. Improved awareness and wider use of recently validated diagnostic imaging methods are urgently required for patients to benefit from recent therapeutic developments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Self-citationTafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021612 · Cited by 2,081
Self-citationInotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
Benson, M. D., Waddington-Cruz, M., Berk, J. L., Polydefkis, M., Dyck, P. J., Wang, A. K., Planté-Bordeneuve, V., Barroso, F. A., Merlini, G., Obici, L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716793 · Cited by 1,452
Self-citationON THE BINDING OF CONGO RED BY AMYLOID
PUCHTLER, H., SWEAT, F., & LEVINE, M. (1962) · Journal of Histochemistry & Cytochemistry · doi:10.1177/10.3.355 · Cited by 1,128
Perugini, E., Guidalotti, P. L., Salvi, F., Cooke, R. M. T., Pettinato, C., Riva, L., Leone, O., Farsad, M., Ciliberti, P., Bacchi-Reggiani, L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.073 · Cited by 981
Vrana, J. A., Gamez, J. D., Madden, B. J., Theis, J. D., Bergen, H. R., & Dogan, A. (2009) · Blood · doi:10.1182/blood-2009-07-230722 · Cited by 904
Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types
Rapezzi, C., Merlini, G., Quarta, C. C., Riva, L., Longhi, S., Leone, O., Salvi, F., Ciliberti, P., Pastorelli, F., Biagini, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843334 · Cited by 774
Self-citationTanskanen, M., Peuralinna, T., Polvikoski, T., Notkola, I., Sulkava, R., Hardy, J., Singleton, A., Kiuru‐Enari, S., Paetau, A., Tienari, P. J., et al. (2008) · Annals of Medicine · doi:10.1080/07853890701842988 · Cited by 591
Frequency and distribution of senile cardiovascular amyloid
Cornwell, G. G., Murdoch, W. L., Kyle, R. A., Westermark, P., & Pitkänen, P. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90443-6 · Cited by 483
Native T1 Mapping in Transthyretin Amyloidosis
Fontana, M., Banypersad, S. M., Treibel, T. A., Maestrini, V., Sado, D. M., White, S. K., Pica, S., Castelletti, S., Piechnik, S. K., Robson, M. D., et al. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2013.10.008 · Cited by 432
Self-citationSenile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
Pinney, J. H., Whelan, C. J., Petrie, A., Dungu, J., Banypersad, S. M., Sattianayagam, P., Wechalekar, A., Gibbs, S. D. J., Venner, C. P., Wassef, N., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000098 · Cited by 372
Self-citationOnline Registry for Mutations in Hereditary Amyloidosis Including Nomenclature Recommendations
Rowczenio, D. M., Noor, I., Gillmore, J. D., Lachmann, H. J., Whelan, C., Hawkins, P. N., Obici, L., Westermark, P., Grateau, G., & Wechalekar, A. D. (2014) · Human Mutation · doi:10.1002/humu.22619 · Cited by 308
Self-citationThe Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans
Quarta, C. C., Buxbaum, J. N., Shah, A. M., Falk, R. H., Claggett, B., Kitzman, D. W., Mosley, T. H., Butler, K. R., Boerwinkle, E., & Solomon, S. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404852 · Cited by 263
Self-citationHutt, D. F., Quigley, A.-M., Page, J., Hall, M. L., Burniston, M., Gopaul, D., Lane, T., Whelan, C. J., Lachmann, H. J., Gillmore, J. D., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu107 · Cited by 250
Self-citationAssociation Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis
Geller, H. I., Singh, A., Alexander, K. M., Mirto, T. M., & Falk, R. H. (2017) · JAMA · doi:10.1001/jama.2017.9236 · Cited by 190
Yanagisawa, A., Ueda, M., Sueyoshi, T., Okada, T., Fujimoto, T., Ogi, Y., Kitagawa, K., Tasaki, M., Misumi, Y., Oshima, T., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.102 · Cited by 161
Benson, M. (2003) · Baillière's Best Practice & Research : Clinical Rheumatology · doi:10.1016/j.berh.2003.09.001 · Cited by 120
Localization of the human prealbumin gene to chromosome 18
Wallace, M. R., Naylor, S. L., Kluve‐Beckerman, B., Long, G. L., McDonald, L., Shows, T. B., & Benson, M. D. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91956-4 · Cited by 115
Booth, D. R., Gallimore, J. R., Hutchinson, W. L., Hohenester, E., Thompson, D. R., Wood, S., & Pepys, M. B. (1998) · Figshare · Cited by 84
A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK
Carr, A. S., Pelayo‐Negro, A. L., Evans, M. R. B., Laurá, M., Blake, J. C., Stancanelli, C., Iodice, V., Wechalekar, A. D., Whelan, C. J., Gillmore, J. D., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310907 · Cited by 67
Self-citationNoninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology
Maurer, M. S. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.05.039 · Cited by 66
Cited by
Kittleson, M. M., Maurer, M. S., Ambardekar, A. V., Bullock-Palmer, R. P., Chang, P. P., Eisen, H. J., Nair, A. P., Nativi-Nicolau, J., Ruberg, F. L., & On behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology (2020) · Circulation · doi:10.1161/cir.0000000000000792 · Cited by 756
Kittleson, M. M., Ruberg, F. L., Ambardekar, A. V., Brannagan, T. H., Cheng, R. K., Clarke, J. O., Dember, L. M., Frantz, J. G., Hershberger, R. E., Maurer, M. S., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.022 · Cited by 640
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy
Gillmore, J. D., Judge, D. P., Cappelli, F., Fontana, M., Garcia-Pavia, P., Gibbs, S., Grogan, M., Hanna, M., Hoffman, J., Masri, A., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2305434 · Cited by 546
Self-citationPatisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis
Maurer, M. S., Kale, P., Fontana, M., Berk, J. L., Grogan, M., Gustafsson, F., Hung, R. R., Gottlieb, R. L., Damy, T., González-Duarte, A., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2300757 · Cited by 339
Self-citationHahn, V. S., Yanek, L. R., Vaishnav, J., Ying, W., Vaidya, D., Lee, Y. Z. J., Riley, S. J., Subramanya, V., Brown, E. E., Hopkins, C. D., et al. (2020) · JACC: Heart Failure · doi:10.1016/j.jchf.2020.04.007 · Cited by 306
Metadata
- Authors
- Lane, T., Fontana, M., Martinez-Naharro, A., Quarta, C. C., Whelan, C. J., Petrie, A., Rowczenio, D. M., Gilbertson, J. A., Hutt, D. F., Rezk, T., Strehina, S. G., Caringal-Galima, J., Manwani, R., Sharpley, F. A., Wechalekar, A. D., Lachmann, H. J., Mahmood, S., Sachchithanantham, S., Drage, E. P. S., Jenner, H. D., McDonald, R., Bertolli, O., Calleja, A., Hawkins, P. N., & Gillmore, J. D.
- Venue
- Circulation
- Published
- 2019-07-02
- Volume
- 140
- Issue
- 1
- Pages
- 16-26
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2944922806
- Cited by
- 535
- References
- 22
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.